Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07921875

Validation of THRIVE and CLEOS Prognostic Models in Taiwanese Patients Undergoing Stroke Thrombectomy

Conditions: Acute Cerebrovascular Accident, Large Vessel Occlusion, Endovascular Thrombectomy, Interventional Radiology, Predictive Model, Outcome Measure

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 233
Sponsor: Kuang Tien General Hospital

Location: Kuang Tien General Hospital Interventional Neuro-radiology Dept. Taichung

Summary

This study will examine how well two existing prediction tools, THRIVE and CLEOS, predict recovery after a stroke caused by a blockage in a large blood vessel in the brain. It will review the medical records of adults who underwent endovascular thrombectomy, a procedure that removes the blood clot, at Kuang Tien General Hospital in Taiwan. THRIVE uses age, stroke severity, and certain existing medical conditions. CLEOS uses age, stroke severity, blood glucose, and information from brain imaging. The study will compare how accurately these tools predict disability and death 90 days after stroke, including recovery among patients whose blocked blood vessels were successfully reopened. The findings may help clinicians discuss expected recovery with patients and families and plan care after stroke. This observational study does not assign treatments or change patients' medical care.

Eligibility Criteria

Inclusion Criteria: * Age 18 years or older at the index stroke; acute ischemic stroke with a large-vessel occlusion confirmed on vascular imaging; EVT initiated by arterial puncture within the defined interval; available records permitting eligibility assessment. Exclusion Criteria: * Prestroke mRS greater than 2; intracranial hemorrhage on initial diagnostic imaging; no arterial puncture/EVT initiation; duplicate index-event records. Reasons are recorded hierarchically in a screening log. Healthy volunteers are not included; all sexes are eligible.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07921875). StuddyBuddy aggregates publicly available trial information.